PATENT CLAIM ANALYSIS

Application Number: 15861974
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "182000"]

Abstract:
This invention relates to Huntington's disease and more specifically to methods for inhibiting the development of or treating Huntington's disease by administering estrogen, testosterone, precursors thereof or combinations thereof.

Claim (Index 10):
The method of  claim 9 , wherein the symptoms of HD comprise weight loss, loss of fine motor function, loss of gross motor function, a loss in cognitive function, chorea, loss of brain tissue, or a combination thereof.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.25926
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12961250', '14334643', '11627978', '14961689', '13988605']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7815813579531843
- 35 USC 102 Novelty (BERT): 0.5901652182795972
- Combined Prediction Score: 0.7624397439858256
- Mean Citation Score: 394.770004
- Max Citation Score: 610.4043
- Similarity Product: 372.8910659184337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test